サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722547

注射器の世界市場レポート：製品、材料、用途、流通チャネル、エンドユーザー、地域別、2025年～2033年

Syringes Market Report by Product, Material, Usage, Distribution Channel, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
注射器の世界市場レポート：製品、材料、用途、流通チャネル、エンドユーザー、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の注射器の市場規模は2024年に211億米ドルに達しました。今後、市場は2033年までに387億米ドルに達し、2025年から2033年にかけて6.99％の成長率（CAGR）を示すと予測されます。個人への迅速かつ安全なワクチン接種を奨励する政府機関による好意的な政策が、市場を活性化する要因のひとつとなっています。

注射器市場分析：

主な市場促進要因：慢性疾患の有病率の上昇が主に市場を強化しています。さらに、外科的介入を受ける人の増加に伴い、麻酔薬を投与するためのシングルユース注射器への嗜好が高まっていることも、重要な成長促進要因として作用しています。

主要市場動向：ヘルスケア従事者や患者の間で感染を回避しながら効率的に滅菌手術を行うことに主要企業が注力していることは、市場を拡大している新たな動向の1つです。これとは別に、使い捨て医療用品の普及がさらに市場にプラスの影響を与えています。

競合情勢：世界市場の著名企業には、B. Braun Melsungen AG、Baxter International Inc.、Becton Dickinson and Company、Cardinal Health Inc.、Gerresheimer AG、Hindustan注射器&Medical Devices Ltd.、Nipro Corporation、Pfizer Inc.、Retractable Technologies Inc.、Schott AG、Smiths Group plc、Terumo Corporation、Thomas Scientific LLCなどがあります。

地理的動向：北米は、安全性と感染制御のための政府機関による多くのイニシアチブの導入により、市場において明確な優位性を示しています。さらに、先進的な製造プロセスが、予測期間中もこの地域の市場を活性化させると思われます。

課題と機会：市場を阻害する主な要因の1つは、針刺し損傷に関連するリスクです。しかし、適切な使用方法と廃棄方法を確保するための医療従事者向けの包括的なトレーニングプログラムの開始は、今後数年間で世界市場を活性化すると予想されます。

注射器市場の動向：

先進的な注射器への需要

注射器の安全性と機能性を高める斬新な先進技術の導入は、注射器市場の展望にプラスの影響を与えています。例えば、2024年3月、自動無効化使い捨て注射器の主要メーカーの一つであるHindustan注射器and Medical Devices（HMD）は、針刺し傷害の発生を最小化する使い捨て安全注射器Dispojektを発表しました。この他、2024年5月、ドイツに本社を置くヘルスケアおよび医薬品パッケージング企業のGerresheimer社は、メキシコのQueretaro施設の拡張を発表し、RTF（Ready-to-Fill）注射器の生産能力を増強し、北米市場の需要に対応します。さらに、在宅ヘルスケアへの嗜好の変化や生物製剤の人気の高まりも市場を後押ししています。例えば、2024年3月、医薬品封じ込めソリューションとデリバリーシステムのプロバイダーの一つであるSCHOTT Pharma社は、mRNA医薬品の深冷保存と輸送のニーズを満たすために必要なプレフィラブルポリマー注射器を製造する米国初の施設をウィルソンに建設しました。この施設ではさらに、糖尿病や肥満を治療するようなGLP-1療法用のガラス製プレフィラブル注射器を製造することができます。

慢性疾患の蔓延

がん、糖尿病、心血管疾患などの慢性疾患の増加により、注射器による定期的かつ正確な投薬の必要性が高まっています。欧州麻薬・薬物中毒監視センター（EMCDDA）と欧州疾病予防管理センター（ECDC）が2023年11月に発表した報告書では、個人間の感染を予防するための注射針・注射器プログラム（NSP）などの介入の有効性が評価されています。さらに、糖尿病の日常管理のためにインスリン注射器が広く使用されていることも市場を強化しています。例えば、テルモインディアは2023年11月、定期的なインスリン注射を必要とする患者向けの無菌送達デバイスであるインスリンシリンジを発売しました。これはテルモメディカルケアソリューションズのライフケアソリューションズ部門に追加されたものです。同シリンジは、インスリン注射を必要とする患者向けに、3ベベルの超鋭利な針と高級シリコンの表面を持つよう特別に設計されており、患者にとって優しく、より快適なものとなっています。また、プランジャー保持技術を採用した独自の機能により、無駄や液漏れを防ぐことができます。さらに、米国糖尿病協会は、米国では数百万人がインスリン注射を必要としていると推定しており、信頼性が高く、使いやすい注射器の需要を促進しています。

安全性への関心の高まり

医療現場における感染管理の改善が重視されるようになり、高度な注射器技術の採用が加速しています。例えば、2024年5月、低分子、生物製剤、ワクチンの無菌注射剤受託製造業者の一つであるGrand River Aseptic Manufacturing（GRAM）は、業界の生物製剤パイプラインの増加や患者の自己投与のための高度ドラッグデリバリーシステムの成長に対応するため、シリンジとカートリッジの生産能力を拡大しました。これとは別に、針刺し損傷を防止するために安全注射器の使用を義務付ける政府機関による厳格な規制の実施は、さらに重要な成長促進要因として作用しています。例えば、2024年3月、米国食品医薬品局（FDA）は、米国内のヘルスケア機関に対し、中国製の特定の未承認プラスチック製注射器の使用を直ちに中止するよう勧告しました。この勧告は、プレフィルド注射器、ガラス製注射器、経口・局所用注射器には適用されません。その結果、大手メーカーは必要不可欠な高品質の医療用製品を投入することで対応しており、今後も市場は活性化すると思われます。例えば、医療技術企業の一つであるBD（ベクトン・ディッキンソン・アンド・カンパニー）は2024年3月、顧客のニーズに応えるため、注射器の国内生産を米国ネブラスカ州とコネチカット州の施設に拡大しました。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の注射器市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 一般的な注射器
  • 専門的注射器
    • 主要セグメント
      • インスリン注射器
      • ツベルクリン注射器
      • アレルギー注射器
  • その他

第7章 市場内訳：材料別

  • ガラス注射器
  • ポリマー注射器

第8章 市場内訳：用途別

  • 使い捨て注射器
    • 主要セグメント
      • 従来の注射器
      • 安全性注射器
      • プレフィルド注射器
  • 再利用可能な注射器

第9章 市場内訳：流通チャネル別

  • オフライン
  • オンライン

第10章 市場内訳：エンドユーザー別

  • 病院と診療所
  • 診断センター
  • 専門センター
  • その他

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Gerresheimer AG
    • Hindustan Syringes & Medical Devices Ltd.
    • Nipro Corporation
    • Pfizer Inc.
    • Retractable Technologies Inc.
    • Schott AG
    • Smiths Group plc
    • Terumo Corporation
    • Thomas Scientific LLC
図表

List of Figures

  • Figure 1: Global: Syringes Market: Major Drivers and Challenges
  • Figure 2: Global: Syringes Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Syringes Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Syringes Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Syringes Market: Breakup by Material (in %), 2024
  • Figure 6: Global: Syringes Market: Breakup by Usage (in %), 2024
  • Figure 7: Global: Syringes Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Syringes Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Syringes Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Syringes (General Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Syringes (General Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Syringes (Specialized Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Syringes (Specialized Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Syringes (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Syringes (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Syringes (Glass Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Syringes (Glass Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Syringes (Polymer Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Syringes (Polymer Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Syringes (Disposable Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Syringes (Disposable Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Syringes (Reusable Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Syringes (Reusable Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Syringes (Offline) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Syringes (Offline) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Syringes (Online) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Syringes (Online) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Syringes (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Syringes (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Syringes (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Syringes (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Syringes (Speciality Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Syringes (Speciality Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Syringes (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Syringes (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Syringes Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Syringes Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Syringes Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Syringes Industry: SWOT Analysis
  • Figure 86: Global: Syringes Industry: Value Chain Analysis
  • Figure 87: Global: Syringes Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Syringes Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Syringes Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Syringes Market Forecast: Breakup by Material (in Million USD), 2025-2033
  • Table 4: Global: Syringes Market Forecast: Breakup by Usage (in Million USD), 2025-2033
  • Table 5: Global: Syringes Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Syringes Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Syringes Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Syringes Market: Competitive Structure
  • Table 9: Global: Syringes Market: Key Players
目次
Product Code: SR112025A5665

The global syringes market size reached USD 21.1 Billion in 2024. Looking forward, the market is expected to reach USD 38.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.99% during 2025-2033. Favorable policies by government bodies for encouraging the fast and safe vaccination of individuals are among the factors fueling the market.

Syringes Market Analysis:

Major Market Drivers: The rising prevalence of chronic diseases is primarily bolstering the market. Moreover, the growing preference for single-use syringes to deliver anesthetics, owing to the increasing number of individuals who are undergoing surgical interventions, is also acting as another significant growth-inducing factor.

Key Market Trends: The inflating focus of key players on efficient sterilizing surgery while avoiding infections among healthcare practitioners and patients is one of the emerging trends augmenting the market. Apart from this, the widespread popularity of disposable medical supplies is further positively influencing the market.

Competitive Landscape: Some of the prominent companies in the global market include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Nipro Corporation, Pfizer Inc., Retractable Technologies Inc., Schott AG, Smiths Group plc, Terumo Corporation, and Thomas Scientific LLC, among many others.

Geographical Trends: North America exhibits a clear dominance in the market, owing to the introduction of numerous initiatives by government bodies for safety and infection control. Furthermore, advanced manufacturing processes will continue to fuel the regional market over the forecasted period.

Challenges and Opportunities: One of the key factors hindering the market is the risk associated with needlestick injuries. However, the launch of comprehensive training programs for healthcare professionals to ensure proper usage and disposal practices is expected to catalyze the global market in the coming years.

Syringes Market Trends:

Demand for Advanced Syringes

The introduction of novel advancements for enhancing the safety and functionality of syringes is positively influencing the syringes market outlook. For example, in March 2024, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of auto-disable and disposable syringes, introduced Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries. Besides this, in May 2024, Gerresheimer, a healthcare and pharmaceutical packaging company based in Germany, announced the expansion of its Queretaro facility in Mexico to increase the production capacities for ready-to-fill (RTF) syringes, thereby catering to the market demand in North America. Additionally, the shifting preference towards home-based healthcare, along with the elevating popularity of biologics, is also propelling the market. For instance, in March 2024, SCHOTT Pharma, one of the pharmaceutical drug containment solutions and delivery systems providers, built its first U.S. facility in Wilson to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications. The site can further produce glass pre-fillable syringes for GLP-1 therapies, such as those that treat diabetes or obesity.

Prevalence of Chronic Diseases

The growing incidences of chronic diseases, including cancer, diabetes, cardiovascular disorders, etc., are escalating the need for regular and precise medication delivery via syringes. The report published by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the European Centre for Disease Prevention and Control (ECDC) in November 2023 assessed the effectiveness of interventions, including needle and syringe programs (NSPs), to prevent infections among individuals. Moreover, the widespread usage of insulin syringes for the daily management of diabetes is also bolstering the market. For instance, in November 2023, Terumo India launched an insulin syringe, a sterile delivery device for patients requiring regular insulin injections. It is the addition to the Life Care Solutions division of Terumo Medical Care Solutions. In line with this, specifically designed to have a 3-bevel super sharp needle with a high-grade silicone surface, the syringe is gentle and more comfortable for patients. Its unique feature with plunger retention technology avoids wastage and spillage. Furthermore, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby driving the demand for reliable and user-friendly syringes.

Increasing Focus on Safety

There is a rising emphasis on improving infection control within healthcare settings, thereby stimulating the adoption of advanced syringe technologies. For example, in May 2024, Grand River Aseptic Manufacturing (GRAM), one of the sterile injectable contract manufacturers of small molecules, biologics, and vaccines, expanded its syringe and cartridge capacity to provide greater capacity for the industry's elevating biologics pipeline and the growth in advanced drug delivery systems for patient self-administration. Apart from this, the implementation of stringent regulations by government bodies that mandate the use of safety syringes to prevent needlestick injuries is further acting as a significant growth-inducing factor. For instance, in March 2024, the Food and Drug Administration (FDA) advised healthcare organizations in the U.S. to immediately transition away from using certain unauthorized plastic syringes made in China. The recommendations do not apply to pre-filled syringes, glass syringes, or syringes utilized for oral or topical purposes. Consequently, leading manufacturers are responding by introducing essential high-quality medical products, which will continue to bolster the market in the coming years. For example, in March 2024, BD (Becton, Dickinson and Company), one of the medical technology companies, elevated domestic manufacturing of syringes in Nebraska and Connecticut facilities, U.S., to cater to customer needs.

Global Syringes Industry Segmentation:

Breakup by Product:

  • General Syringes
  • Specialized Syringes
  • Insulin Syringes
  • Tuberculin Syringes
  • Allergy Syringes
  • Others

Among these, general syringes currently exhibit a clear dominance in the market

General syringes, essential tools in medical and healthcare settings, are continually evolving with advancements in technology and design aimed at improving safety, accuracy, and convenience. One of the notable launches is the Medtronic MiniMed 770G Insulin Pump System, which integrates advanced smart technology for precise insulin delivery, catering specifically to diabetes patients. General syringes improve user safety and reduce the risk of accidental injuries, thereby driving the segment's growth.

Breakup by Material:

  • Glass Syringes
  • Polymer Syringes

Currently, glass syringes hold the largest market share

Glass syringes are a crucial component in the medical field, valued for their durability, chemical resistance, and precise delivery capabilities. Unlike plastic syringes, they do not interact with the medications they contain, thereby making them ideal for administering highly reactive or sensitive drugs, such as biologics and certain vaccines. Their use is prominent in the pharmaceutical and biotechnology industries, where maintaining the integrity of the substance is paramount. In January 2024, Schreiner MediPharm, a Germany-based global provider of functional label solutions for the healthcare industry, developed barrier function labels that are generally designed to protect against oxygen ingress for drugs contained in COC syringes.

Breakup by Usage:

  • Disposable Syringes
  • Conventional Syringes
  • Safety Syringes
  • Prefilled Syringes
  • Reusable Syringes

Disposable syringes hold the largest share in the market

Disposable syringes have become an indispensable tool in modern healthcare due to their convenience, affordability, and ability to reduce the risk of cross-contamination and infection significantly. Designed for single use, these syringes are typically made from plastic and come pre-sterilized, ensuring a high standard of hygiene. Their widespread adoption has been driven by health initiatives aiming to combat the spread of infectious diseases. According to the report by IMARC, the global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.

Breakup by Distribution Channel:

  • Offline
  • Online

The offline segment, which includes hospitals, clinics, and retail pharmacies, continues to dominate the market due to the immediate availability of products and the trust consumers place in physical purchases, especially for critical healthcare supplies. This traditional distribution method is bolstered by strong relationships between manufacturers and healthcare providers, ensuring a steady supply chain and reliable access to syringes. Conversely, the online segment is experiencing rapid growth, driven by the increasing adoption of e-commerce platforms in the healthcare sector. Online distribution offers significant advantages such as convenience, wider product availability, and competitive pricing, which are particularly appealing to individual consumers and smaller healthcare facilities. Major players in the market, like Becton Dickinson (BD) and Terumo, are leveraging digital platforms to expand their reach and enhance customer engagement.

Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Speciality Centers
  • Others

Syringes play a critical role across various healthcare settings. In hospitals and clinics, they are indispensable for a wide range of procedures, from routine vaccinations and blood draws to administering medications and intravenous therapies. Their reliability and ease of use make them a staple in these high-demand environments. Diagnostic centers heavily rely on syringes for sample collection and diagnostic testing, ensuring accurate and sterile handling of specimens. Specialty centers, such as oncology and diabetes care facilities, utilize them for precise administration of treatments like chemotherapy and insulin, which require meticulous dosing and safety. Other settings, such as outpatient care centers and emergency medical services, depend on syringes for immediate, on-the-go medical interventions, highlighting their versatility and importance in diverse medical scenarios.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America currently dominates the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the syringes market overview, the rising prevalence of chronic diseases, increased vaccination efforts, and advancements in medical technology are acting as growth-inducing factors in North America. Moreover, in the United States, stringent safety regulations set by the Occupational Safety and Health Administration (OSHA) have led to the widespread adoption of safety-engineered syringes that are designed to minimize needlestick injuries and enhance user safety. Besides this, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby escalating the use of reliable and user-friendly syringes. Furthermore, prominent players like Becton Dickinson (BD) and Novo Nordisk are leading the market with their advanced insulin delivery systems.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Cardinal Health Inc.
  • Gerresheimer AG
  • Hindustan Syringes & Medical Devices Ltd.
  • Nipro Corporation
  • Pfizer Inc.
  • Retractable Technologies Inc.
  • Schott AG
  • Smiths Group plc
  • Terumo Corporation
  • Thomas Scientific LLC

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Syringes Market Recent Developments:

May 2024: Gerresheimer, one of the healthcare and pharmaceutical packaging companies based in Germany, expanded its Queretaro capacity of ready-to-fill (RTF) syringes in Mexico.

March 2024: SCHOTT Pharma built its first U.S. facility to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications.

March 2024: Hindustan Syringes and Medical Devices (HMD), one of the leading providers of auto-disable and disposable syringes, launched Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries.

Key Questions Answered in This Report

  • 1.What was the size of the global syringes market in 2024?
  • 2.What is the expected growth rate of the global syringes market during 2025-2033?
  • 3.What are the key factors driving the global syringes market?
  • 4.What has been the impact of COVID-19 on the global syringes market?
  • 5.What is the breakup of the global syringes market based on the product?
  • 6.What is the breakup of the global syringes market based on the material?
  • 7.What is the breakup of the global syringes market based on usage?
  • 8.What are the key regions in the global syringes market?
  • 9.Who are the key players/companies in the global syringes market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Syringes Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 General Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Specialized Syringes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Insulin Syringes
      • 6.2.2.2 Tuberculin Syringes
      • 6.2.2.3 Allergy Syringes
    • 6.2.3 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Glass Syringes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymer Syringes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Usage

  • 8.1 Disposable Syringes
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Conventional Syringes
      • 8.1.2.2 Safety Syringes
      • 8.1.2.3 Prefilled Syringes
    • 8.1.3 Market Forecast
  • 8.2 Reusable Syringes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Offline
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Diagnostic Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Speciality Centers
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 B. Braun Melsungen AG
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 SWOT Analysis
    • 16.3.2 Baxter International Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Becton Dickinson and Company
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Cardinal Health Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Gerresheimer AG
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Hindustan Syringes & Medical Devices Ltd.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Nipro Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Pfizer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Retractable Technologies Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 Schott AG
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 SWOT Analysis
    • 16.3.11 Smiths Group plc
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Terumo Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thomas Scientific LLC
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio